Treatment with FTY720 during the induction or effector phase suppresses the development of experimental allergic conjunctivitis in mice

被引:9
作者
Sumi, Tamaki [1 ]
Fukushima, Atsuki [1 ]
Nishino, Koji [1 ]
Fukuda, Ken [2 ]
Kumagai, Naoki [2 ]
Nishida, Teruo [2 ]
Ueno, Hisayuki [1 ]
机构
[1] Kochi Med Sch, Dept Ophthalmol & Visual Sci, Nankoku, Kochi 7838505, Japan
[2] Yamaguchi Univ, Sch Med, Dept Ophthalmol, Yamaguchi, Japan
关键词
Allergic conjunctivitis; Eosinophil; FTY720; Splenocyte; Th2; IMMUNE-MEDIATED BLEPHAROCONJUNCTIVITIS; C57BL/6; MICE; IMMUNOSUPPRESSANT; CELLS; KERATOCONJUNCTIVITIS; RESPONSES; DISEASE; TISSUES; DRUGS; MODEL;
D O I
10.1016/j.cellbi.2009.02.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Purpose: To investigate whether experimental allergic conjunctivitis (EC) can be suppressed by treatment with the immunomodulatory drug FTY720, which reduces the recruitment of effector T cells into inflammatory sites. Methods: BALB/c mice were actively immunized with ragweed (RW) and then injected intraperitoneally with FTY720 on days 0, 2, 4, 6 and 8 (induction phase treatment) followed by challenge on day 10 with RW-containing eye drops. Alternatively, naive mice that received RW-primed splenocytes were injected intraperitoneally with FTY720 on days 2 and 4 (effector phase treatment) followed by RW challenge on day 4. Twenty-four hours after RW challenge, conjunctivas and spleens were harvested for histology or immunohistochemistry, and flow cytometric analysis or cytokine assays, respectively. Results: FTY720 treatment during the induction phase suppressed the conjunctival infiltration of T cells as well as eosinophils and macrophages. The splenocytes from induction phase-treated mice contained significantly less CD4(+) and CD8(+) T cells and showed significant suppression of Th2 but not Th1 cytokine production. Effector phase treatment with FTY720 suppressed conjunctival eosinophil infiltration. Conclusions: These data demonstrate that FTY720 treatment during the induction phase decreases the absolute number of CD4(+) and CD8(+) T cells in the spleen and suppresses Th2 cytokine production by splenocytes. This leads to the suppression of EC. FTY720 treatment also suppresses EC when delivered during the effector phase. Thus, FTY720 treatment may be suitable for treating severe forms of vernal keratoconjunctivitis. (C) 2009 International Federation for Cell Biology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:534 / 541
页数:8
相关论文
共 21 条
[1]   VERNAL KERATOCONJUNCTIVITIS - A MODEL OF 5Q CYTOKINE GENE-CLUSTER DISEASE [J].
BONINI, S ;
BONINI, S ;
LAMBIASE, A ;
MAGRINI, L ;
RUMI, C ;
DELPRETE, G ;
SCHIAVONE, M ;
ROTIROTI, G ;
ONORATI, P ;
RUTELLA, S .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1995, 107 (1-3) :95-98
[2]   Pharmacodynamics of single doses of the novel immunosuppressant FTY720 in stable renal transplant patients [J].
Budde, K ;
Schmouder, RL ;
Nashan, B ;
Brunkhorst, R ;
Lücker, PW ;
Mayer, T ;
Brookman, L ;
Nedelman, J ;
Skerjanec, A ;
Böhler, T ;
Neumayer, HH .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (07) :846-854
[3]  
Butrus Salim, 2005, Ophthalmol Clin North Am, V18, P485
[4]   FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors [J].
Chiba, K .
PHARMACOLOGY & THERAPEUTICS, 2005, 108 (03) :308-319
[5]  
FRIEDLAENDER MH, 1984, ARCH OPHTHALMOL-CHIC, V102, P1198
[6]   Genetic background determines susceptibility to experimental immune-mediated blepharoconjunctivitis: Comparison of Balb/c and C57BL/6 mice [J].
Fukushima, A ;
Yamaguchi, T ;
Ishida, W ;
Fukata, K ;
Taniguchi, T ;
Liu, FT ;
Ueno, H .
EXPERIMENTAL EYE RESEARCH, 2006, 82 (02) :210-218
[7]   The interaction between ICOS and B7RP-1 is not required for the development of experimental murine allergic conjunctivitis [J].
Fukushima, A ;
Yamaguchi, T ;
Ishida, W ;
Fukata, K ;
Yagita, H ;
Ueno, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 338 (04) :1726-1731
[8]   Dissection of antigen-specific humoral and cellular immune responses for the development of experimental immune-mediated blepharoconjunctivitis in C57BL/6 mice [J].
Fukushima, A ;
Ozaki, A ;
Jian, Z ;
Ishida, W ;
Fukata, K ;
Ueno, H ;
Liu, FT .
CURRENT EYE RESEARCH, 2005, 30 (04) :241-248
[9]   Ag-specific recognitiong activationg and effector function of T cells in the conjunctiva with experimental immune-mediated blepharoconjunctivitis [J].
Fukushima, A ;
Ozaki, A ;
Fukata, K ;
Ishida, W ;
Ueno, H .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (10) :4366-4374
[10]   CD8+T cells play disparate roles in the induction and the effector phases of murine experimental allergic conjunctivitis [J].
Fukushima, Atsuki ;
Yamaguchi, Tomoko ;
Fukuda, Ken ;
Sumi, Tamaki ;
Kumagai, Naoki ;
Nishida, Teruo ;
Imai, Shosuke ;
Ueno, Hisayuki .
MICROBIOLOGY AND IMMUNOLOGY, 2006, 50 (09) :719-728